Appointment of liquidators (CVL)
IMPJAR ELIQUID LTD
The notice announces the appointment of liquidators Nedim Ailyan and Paul Atkinson for IMPJAR ELIQUID LTD in a creditors' liquidation.
Notice details
- Company
- IMPJAR ELIQUID LTD
- Company number
- 14371042
- Nature of business
- Manufacture of Liquids for Vape Products
- Registered office
- 6-7 Cecil Square, Margate, Kent, CT9 1BD
- Principal trading address
- Centre Block, 4th Floor, Central Court, Knoll Rise, Orpington, BR6 0JA (in process of being changed)
- Type of liquidation
- Creditors
- Date of appointment
- 26 August 2026
- Liquidator(s)
- Nedim Ailyan (IP No. 9072); Paul Atkinson (IP No. 9314)
- Appointed by
- Members and Creditors
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If IMPJAR ELIQUID LTD owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at IMPJAR ELIQUID LTD or something similar, start the conversation early.
If your business is under pressure — creditors circling, a petition threatened, or cash running out — acting early changes the outcome. K2 has helped UK directors turn things around since 1990. Talk to us in confidence.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.